Upper GI Tract
From the Journals
Study supports swallowed topical steroids as maintenance for eosinophilic esophagitis
Rates of clinical remission were 16.1% and 1.3%, respectively (P less than .001).
From the Journals
No difference between PPI prophylaxis, placebo for GI bleeding
There was no significant difference in mortality between critically ill patients who received pantoprazole prophylaxis for gastrointestinal...
From the Journals
Anticoagulant choice, PPI cotherapy impact risk of upper GI bleeding
PPI cotherapy lowered overall incidence of gastrointestinal bleeding.
From the AGA Journals
Surgical model to study reflux esophagitis after esophagojejunostomy
Post esophagojejunostomy in rats, a wound repair process produces metaplastic columnar-lined esophagus likely independent of progenitor cell...
From the Journals
AGA Clinical Practice Update: Diagnosis of rumination syndrome
From the Journals
Experts update diagnostic guidelines for eosinophilic esophagitis
The diagnosis no longer needs to include a trial of proton pump inhibitor therapy.
From the Journals
GERD patients who fail PPI often have functional heartburn or hypersensitivity
Reflux characteristics and pH levels were not significantly different between GERD patients who improved on PPI therapy and those who did not.
From the Journals
POEM effective for more than achalasia
Conference Coverage
Eosinophilic esophagitis: Faces and facets of a new disease
While still a young disease, EoE has evolved from esoterica to a leading cause of dysphagia and food impaction worldwide.
Practice Management Toolbox
Patient-reported outcomes in esophageal diseases
Multiple well-constructed PROs exist for symptom domains such as dysphagia and heartburn, and can be used to monitor symptoms over time and assess...